UK markets closed

Cyclacel Pharmaceuticals, Inc. (CYCC)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.2900-0.0500 (-2.14%)
At close: 04:00PM EDT
2.2600 -0.03 (-1.31%)
After hours: 05:38PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
3,378
18,345
36,559
33,406
Total cash
3,378
18,345
36,559
33,406
Other current assets
341
426
79
66
Total current assets
7,444
24,411
40,942
35,469
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
522
557
455
2,218
Accumulated depreciation
-420
-383
-361
-886
Net property, plant and equipment
102
174
94
1,332
Total non-current assets
1,361
3,639
2,194
1,332
Total assets
8,805
28,050
43,136
36,802
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
3,543
2,561
2,117
514
Accrued liabilities
4,238
3,944
2,543
1,106
Other current liabilities
380
1,006
753
866
Total current liabilities
8,161
7,511
5,413
2,486
Non-current liabilities
Total non-current liabilities
37
106
30
1,057
Total liabilities
8,198
7,617
5,443
3,543
Stockholders' equity
Common stock
1
4,495
10
6
Retained earnings
-428,282
-405,727
-384,529
-366,072
Accumulated other comprehensive income
-908
-1,316
-748
-746
Total stockholders' equity
607
20,433
37,693
33,259
Total liabilities and stockholders' equity
8,805
28,050
43,136
36,802